HomeZYDUSLIFE • NSE
add
Zydus Lifesciences Ltd
Previous close
₹944.05
Day range
₹939.60 - ₹952.00
Year range
₹628.10 - ₹1,324.30
Market cap
954.81B INR
Avg Volume
1.07M
P/E ratio
22.24
Dividend yield
0.32%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 52.37B | 19.87% |
Operating expense | 25.83B | 28.18% |
Net income | 9.11B | 13.80% |
Net profit margin | 17.40 | -5.07% |
Earnings per share | 9.05 | 14.27% |
EBITDA | 14.07B | 32.51% |
Effective tax rate | 28.86% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.95B | 64.20% |
Total assets | 314.46B | 21.51% |
Total liabilities | 72.91B | 47.64% |
Total equity | 241.55B | — |
Shares outstanding | 1.01B | — |
Price to book | 4.35 | — |
Return on assets | — | — |
Return on capital | 12.51% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 9.11B | 13.80% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
Founded
1952
Website
Employees
26,921
